During the past decade, Ortenau Klinikum conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ortenau Klinikum" #1 sponsor was "University of Ulm" with 5 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 3 trials sponsored, "AGO Research GmbH" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored and "Arcagy Research" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ortenau Klinikum" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Ortenau Klinikum" are "Acute Myeloid Leukemia" (6 trials), "Lymphoma" (3 trials), "Acute Myeloid Leukemia (AML)" (2 trials), "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Ortenau Klinikum" in a lesser frequency.

Most popular intervention types in "Ortenau Klinikum" are "Drug" (14 trials), "Biological" (4 trials), "Radiation" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (3 trials), "Daunorubicin" (3 trials), "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials) and "prednisone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ortenau Klinikum" are 12 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Ortenau Klinikum". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ortenau Klinikum, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ortenau Klinikum, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".